Nordson Corporation (NDSN)
適正価値ファンダメンタル
71
株価
$327.80
時価総額
$18.01B
パート1 · 企業の価値
概要
Nordson makes precision dispensing equipment: machines that apply exact, controlled amounts of adhesives, coatings, sealants and other fluids inside a factory line, plus components used in medical devices and semiconductor manufacturing. Its products are typically a small line item inside a much larger production process — a diaper plant's glue applicator, a chip packaging step, a catheter's plastic tubing — but a failure or imprecision there can shut the whole line down.
収益の仕組み
Revenue comes mostly from selling dispensing systems and components once, plus recurring sales of spare parts, nozzles and service that keep those systems running precisely over years of use. Because customers integrate Nordson's equipment into a validated production process, replacing it later requires re-qualifying the whole line, which supports steady repeat business rather than one-off equipment sales.
セグメント別売上高
Adhesive, coating and sealant dispensing systems sold into packaging, general industrial and consumer goods production lines.
Components and precision fluid-management systems used in medical devices such as catheters, plus fluid dispensing for other industries.
Equipment used in semiconductor and electronics manufacturing, including chip packaging and testing steps.
競争優位性(moat)
スイッチングコスト · 狭いOnce a customer validates a production line around Nordson's dispensing equipment — calibrated to exact fluid volumes and tolerances, sometimes under regulatory approval as in medical devices — swapping to a competitor means re-validating the whole line, a costly and slow process manufacturers avoid unless something is badly wrong. That keeps replacement parts and service revenue sticky even where the original equipment sale was competitive.
需要を左右する要因
中程度の景気循環性Demand splits between steadier end markets — packaging, medical devices, consumer nondurables — and more cyclical ones like semiconductor and electronics capital spending, which swings with chip industry investment cycles. The mix of the three segments smooths some of that cyclicality but does not remove it, particularly in the Advanced Technology segment.
主なリスク
- Cyclicality in semiconductor capital spending — The Advanced Technology Solutions segment depends on chip makers' capital equipment budgets, which are historically volatile and can swing sharply between shortage and oversupply periods.
- Acquisition integration risk — Nordson has grown its segments partly through acquisitions; integrating acquired businesses' operations, systems and customer relationships carries execution risk and can strain expected returns.
- Customer capital spending decisions — Equipment sales depend on customers deciding to build or upgrade production lines, decisions that can be postponed in an uncertain economic environment even when replacement parts demand continues.
- International operations and currency exposure — A significant share of sales and manufacturing occurs outside the United States, exposing results to currency translation and to economic and trade conditions in those markets.
強気材料
Buyers argue that Nordson's equipment gets embedded in validated production lines across three diversified end markets, that recurring parts and service revenue smooths the cycle, and that record fiscal 2025 results show the model compounding through both steadier and more cyclical segments at once.
弱気材料
Sellers fear that the Advanced Technology segment remains exposed to a genuinely volatile semiconductor capital-spending cycle, that growth built partly through acquisitions carries integration risk that can disappoint, and that a broader industrial slowdown would delay the equipment upgrades that drive the larger, steadier segments too.
Written by the editors, published on 2026年8月18日
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
貸借対照表と流動性
売上高
$2.98B
直近12か月(2026/7/31まで)
純利益
$555M
直近12か月(2026/7/31まで)
フリーキャッシュフロー
$661M
自己資本合計
$3.04B
負債合計
$2.87B
流動比率
1.82
利払い倍率
8.83
負債/EBITDA
2.30
一株当たり利益(EPS)
売上高と純利益
フリーキャッシュフロー
収益内訳
財務推移表
利益率の推移
負債の推移
負債の重さ
成長率グリッド
成長率 — 売上高
適正価値の推定
適正価値
$294.61
現在株価
$327.80
安全マージン
-11.3%
適正価値レンジ
$226.16 - $363.07
使用した評価手法間のばらつきであり、統計的に較正された信頼区間ではありません。
推定方法
バリュエーション指標
P/E レシオ
33.22
ROE
15.9%
P/B レシオ
5.59
P/FCF
25.22
粗利益率
55.3%
ROIC
12.1%
収益性レーダー
価値創造(経済的モート)
ROIC
12.1%
WACC
9.5%
ROIC − WACC
+2.6 pp
ROICが資本コストを上回っています。企業は株主のために価値を創出しています。
ファンダメンタル分析基準
合格(21)
- EPS shows upward trend
- EPS CAGR 5.49%
- Price CAGR 11.11%
- ROIC 12.1%
- Gross Margin 55.3%
- P/FCF 25.22
- Debt/Equity ratio
- Operating Margin 26.9%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 17.6%
- Revenue Growth 5Y 5.7%
- Analyst Consensus 60% Buy
- Earnings Quality (OCF/NI) 1.39
- Share Dilution -1.2%
- Net Margin Trend 18.6% vs 16.3%
- Piotroski F-Score 7/9
不合格(6)
- P/B Ratio 5.59
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Earnings Surprise avg 0.3%
- PEG Ratio 2.18
データなし(1)
- Dividend Payout NaN%
Piotroski F-スコア
財務健全性が高い
利益の質
高品質:利益はキャッシュに裏付けられている
株式希薄化
株式を買い戻している。株主に友好的
機関投資家の保有
ガバナンス
経営陣
| 氏名 | 役職 | 年齢 |
|---|---|---|
| Mr. Sundaram Nagarajan | President, CEO & Director | 62 |
| Mr. Daniel R. Hopgood | Executive VP & CFO | 52 |
| Ms. Jennifer L. McDonough J.D. | Executive VP, General Counsel & Corporate Secretary | 53 |
| Mr. Joseph P. Kelley | Executive VP of Industrial Precision Solutions Leader | 52 |
| Mr. Joseph M. Rutledge | VP & Chief Accounting Officer | 45 |
| Ms. Lara L. Mahoney | Vice President of Investor Relations & Corporate Communications | - |
| Katie Colacarro | Vice President of Corporate Development | - |
| Ms. Sarah Siddiqui | Executive VP & Chief Human Resources Officer | 47 |
| Mr. Justin Hall | Executive Vice President of Medical & Fluid Solutions | 46 |
| Mr. Matthew Matejka | Senior Director of Investor Relations | - |
監査リスク
8
取締役会リスク
3
報酬リスク
6
株主権利リスク
10
パート2 · 株価と買い時
この部分は企業に価値があるかを判断するものではありません。ファンダメンタルズに納得したうえで、いつ買うかを選ぶためのものです。内容:テクニカル分析、ポテンシャル、過去のドローダウン、ガンマエクスポージャー。
業績推移
via SEC EDGAR
Latest News
Recent headlines for NDSN, sourced from Markets Gazette.
- 8/21/2026POSITIVEThursday’s Activity, 4 Possible Friday Plays
Nordson Corporation (NDSN) was highlighted as a potential multi-bagger opportunity in Thursday's trading session, with the NDSN Weekly $310-320 call options showing significant upside potential. The article suggests that the stock has delivered strong performance, aligning with the firm's successful track record of identifying profitable trading plays. Investors who followed this recommendation may have seen substantial gains, indicating positive momentum for the company's stock.
via Markets Gazette